New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
$9.8 million NCI grant aims to combat cancer disparities

$9.8 million NCI grant aims to combat cancer disparities

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat can
World medicine November 19,2023
$9.8 million NCI grant aims to combat cancer disparities

$9.8 million NCI grant aims to combat cancer disparities

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat can
World medicine November 19,2023
Expert panel develops first-ever guideline to treat tooth decay in primary and permanent teeth

Expert panel develops first-ever guideline to treat tooth decay in primary and permanent teeth

A new American Dental Association (ADA) clinical practice guideline suggests conservative methods to treat tooth decay in primary and permanent teeth could lead to better outcomes when used with commo
Stomatology November 19,2023
Expert panel develops first-ever guideline to treat tooth decay in primary and permanent teeth

Expert panel develops first-ever guideline to treat tooth decay in primary and permanent teeth

A new American Dental Association (ADA) clinical practice guideline suggests conservative methods to treat tooth decay in primary and permanent teeth could lead to better outcomes when used with commo
Stomatology November 19,2023
Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer.Led by Associate Prof
World medicine November 19,2023
Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

Researchers pinpoint a key feature that leads to aggressive spread of colon cancer

In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer.Led by Associate Prof
World medicine November 19,2023
Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

By monitoring early-response biomarkers in men undergoing177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes. In a study p
World medicine November 19,2023
Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

By monitoring early-response biomarkers in men undergoing177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes. In a study p
World medicine November 19,2023
Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

Cancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency department (ED) visits and hospitalizations, according to new research
World medicine November 19,2023
Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

Cancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency department (ED) visits and hospitalizations, according to new research
World medicine November 19,2023
Seven risk factors for early onset colorectal cancer in males identified

Seven risk factors for early onset colorectal cancer in males identified

Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but are increasing for those under 50.A new study, led by researcher-clinician Thomas Imperiale, M.D., of the U.S
World medicine November 19,2023
Seven risk factors for early onset colorectal cancer in males identified

Seven risk factors for early onset colorectal cancer in males identified

Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but are increasing for those under 50.A new study, led by researcher-clinician Thomas Imperiale, M.D., of the U.S
World medicine November 19,2023
AI model can help doctors determine the extent of cancer within the prostate

AI model can help doctors determine the extent of cancer within the prostate

FindingsA new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors dete
World medicine November 19,2023
AI model can help doctors determine the extent of cancer within the prostate

AI model can help doctors determine the extent of cancer within the prostate

FindingsA new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors dete
World medicine November 19,2023
Food for thought: South European Atlantic diet shows promising link to lower depression risk

Food for thought: South European Atlantic diet shows promising link to lower depression risk

Healthy eating trends can positively impact mental health; however, it remains unclear whether the South European Atlantic Diet (SEAD) is associated with mental health problems. In a recent study publ
World medicine November 19,2023
Food for thought: South European Atlantic diet shows promising link to lower depression risk

Food for thought: South European Atlantic diet shows promising link to lower depression risk

Healthy eating trends can positively impact mental health; however, it remains unclear whether the South European Atlantic Diet (SEAD) is associated with mental health problems. In a recent study publ
World medicine November 19,2023
New technique shows potential to generically treat several kinds of cancer

New technique shows potential to generically treat several kinds of cancer

Researchers led by Katsunori Tanaka at the RIKEN Cluster for Pioneering Research (CPR) in Japan and Hiromitsu Haba at the RIKEN Nishina Center for Accelerator-Based Science (RNC) have developed a new
World medicine November 19,2023
New technique shows potential to generically treat several kinds of cancer

New technique shows potential to generically treat several kinds of cancer

Researchers led by Katsunori Tanaka at the RIKEN Cluster for Pioneering Research (CPR) in Japan and Hiromitsu Haba at the RIKEN Nishina Center for Accelerator-Based Science (RNC) have developed a new
World medicine November 19,2023
New radionuclide-based agent offers hope for treating a variety of cancers

New radionuclide-based agent offers hope for treating a variety of cancers

A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a
World medicine November 19,2023
New radionuclide-based agent offers hope for treating a variety of cancers

New radionuclide-based agent offers hope for treating a variety of cancers

A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a
World medicine November 19,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com